Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Solventum (SOLV) EBT (2023 - 2025)

Solventum (SOLV) has disclosed EBT for 3 consecutive years, with $58.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 346.15% year-over-year to $58.0 million, compared with a TTM value of $1.7 billion through Dec 2025, up 183.14%, and an annual FY2025 reading of $1.7 billion, up 183.14% over the prior year.
  • EBT was $58.0 million for Q4 2025 at Solventum, down from $1.5 billion in the prior quarter.
  • Across five years, EBT topped out at $1.5 billion in Q3 2025 and bottomed at $13.0 million in Q4 2024.
  • Average EBT over 3 years is $332.1 million, with a median of $248.0 million recorded in 2024.
  • The sharpest move saw EBT plummeted 96.68% in 2024, then soared 806.59% in 2025.
  • Year by year, EBT stood at $391.0 million in 2023, then tumbled by 96.68% to $13.0 million in 2024, then soared by 346.15% to $58.0 million in 2025.
  • Business Quant data shows EBT for SOLV at $58.0 million in Q4 2025, $1.5 billion in Q3 2025, and $103.0 million in Q2 2025.